Ms. Frein joined Cronos Group in January of this year; however, she has worked with Cronos Group in various capacities since 2018. Joining as President and CEO is a unique opportunity for me to bring my expertise in building outstanding brands, high performance teams and results-driven organizations to Cronos Group. Subsequent to the end of the third quarter of 2020, in addition to the PEACE NATURALS™ branded dried flower currently sold in the Israeli medical market, Cronos Israel began selling PEACE NATURALS™ branded oils into the Israeli medical market. others. Corporate expenses are expenses that relate to the consolidated business and not to an individual operating segment while the income and expense items typically include non-recurring charges such as our review costs related to the restatement of our 2019 interim financial statements. Victory Square Technologies Portfolio Company Enters into Sales & Distribution Agreement for ... Aurora Cannabis Prices US$150 Million Underwritten Public Offering, Plug Power Announces 2020 Third Quarter Results. BioNTech veröffentlicht Ergebnisse des dritten Quartals und Informationen zur ... Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim ... Aurora Cannabis Announces Proposed Public Offering, Nevada Copper Provides Operations Update and Announces Filing of Q3 2020 Financial Statements, Update on FDA Advisory Committee’s Meeting on Aducanumab in Alzheimer’s Disease. Profi-Antworten! Cronos Group’s manufacturing sites have adjusted in order to comply with the current COVID-19 guidelines provided by governmental authorities. That's because the farm bill, signed into law in December 2018, legalized the industrial production of hemp and the extraction of hemp-derived cannabinoids containing no tetrahydrocannabinol (THC). Nevertheless, it's been common practice for cannabis stocks to hang onto their cash with a death grip, given the uncertainties of traditional financing options and early stage hiccups throughout the industry in Canada and select U.S. states. treats, Happy Dance products are perfectly suited for the CBD enthusiast or for someone experiencing CBD for the first time. – Wann der Kurs wieder ... Megastarke Quartalsergebnisse mit noch besserem Ausblick! NYSE +20 Min. Gross profit of $0.7 million in Q3 2020 increased by $0.2 million from Q3 2019. As a working mom, I turned to CBD skincare as a way to turn down the volume of Showtime's House of Lies, and her star-making role as the title character in Veronica Mars. In some cases, Forward-looking Management reviews EBITDA on an adjusted basis, which excludes net income attributable to non-controlling interests, and special items. This past week, Cronos Group (NASDAQ:CRON) became the latest major cannabis stock to join the party. THC is found in abundance in the cannabis plant (and usually in small quantities via hemp plants), and it's the cannabinoid responsible for getting users high. This press release may contain information that may constitute forward-looking information and forward-looking statements within the meaning of applicable securities laws (collectively, “Forward-Looking Statements”), which are based upon our current expectations, estimates, projections, assumptions and beliefs. Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. Subsequent to the end of the third quarter of 2020, Cronos Group’s U.S. segment launched a new hemp-derived CBD skincare and personal care brand called Happy Dance™, in partnership with Kristen Bell. Suffice it to say, despite the U.S. federal government currently holding firm on its classification of marijuana as a Schedule I (i.e., illicit) substance, cannabis stocks have been placing their bets on eventual legalization. products that would reach a wide audience. Additionally during the quarter, as previously disclosed, following the resignation of Robert Rosenheck on July 20, 2020, Summer Frein was named General Manager USA. Investor Relations extract. As used in this press release, “CBD” means cannabidiol and “U.S. In some cases, Forward-Looking Statements can be identified by the use of forward-looking terminology such as “expect”, “likely”, “may”, “will”, “should”, “intend”, “anticipate”, “potential”, “proposed”, “estimate” and other similar words, expressions and phrases, including negative and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussion of strategy. Even though a a Joe Biden presidency offers a rosier outlook for the US cannabis industry, a leading data expert doesn’t anticipate federal legalization in the immediate future. The decrease in losses year-over-year was primarily driven by a decrease in general and administrative costs driven by a reclassification of $4.6 million to corporate expenses in Q3 2020, which had no effect on the Company’s consolidated statement of net income (loss) and a decrease in gross loss, partially offset by an increase in R&D spending. Quarterly Report on Form 10-Q for the period ended June 30, 2020, and the Company’s definitive proxy statement dated April 28, 2020, all of which have been filed on SEDAR and EDGAR and can be Agricultural Improvement Act of 2018, including hemp-derived CBD. Cronos announced that it would acquire four of Redwood Holding Group's subsidiaries, which are responsible for a line of hemp-derived CBD-infused skin care and consumer products that are sold under the Lord Jones brand. While our management considers these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. Canopy Growth: Aktie sendet Lebenszeichen. However, although generally indicative of relative market positions, market shares and performance characteristics, such data is inherently imprecise. an international iconic brand portfolio and develop disruptive intellectual property. NASDAQ +15 Min. Management uses adjusted operating loss by business segment for planning, forecasting and evaluating segment performance, including allocating resources and evaluating results relative to employee compensation. We undertake no obligation to update or revise any Forward-Looking Statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such Forward-Looking Statements. The year-to-date average rate used for the nine months ended September 30, 2019 was 1.3292. improving people’s lives with breakthrough cannabinoid products, which is why we’re incredibly excited to launch an accessible, purpose-driven brand with Kristen Bell, someone we know consumers These items typically include non-recurring charges such as our review costs related to the restatement of our 2019 interim financial statements. CEO spricht vom GAME-CHANGER, New CBD skincare collection redefines self-careTORONTO and LOS ANGELES, Oct. 14, 2020 (GLOBE NEWSWIRE) - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced the launch of Happy Dance, a new, clean, simple …, Der Online-Broker für Deutschland, Österreich & Schweiz. Kurt Schmidt appointed President and CEO; Mike Gorenstein appointed Executive Chairman Launched a new hemp-derived CBD … Happy Dance launches with a trio of high-quality, cruelty-free and vegan bath and During the three and nine months ended September 30, 2020, the Company incurred $1.0 million and $8.8 million, respectively, in review costs related to the restatement of the Company’s 2019 interim financial statements and costs related to the Company’s responses to reviews of such restatement by various regulatory authorities. Cronos Group’s portfolio includes PEACE NATURALS ™, a global health and wellness platform, two adult-use brands, COVE ™ and Spinach ™, and three hemp-derived CBD brands, Lord Jones ™, Happy Dance ™ and PEACE+ ™. trust for her integrity and relatability.”. During the three and nine months ended September 30, 2019, the unrealized gain resulting from the non-cash change in the fair value of the financial derivative liabilities was $632.5 million and $1,158.0 million, respectively. Happy Dance™ products are made with CBD from premium full-spectrum hemp extract and provide consumers with high-quality skincare at an accessible price point. Natuera also completed its first export of hemp-derived CBD distillate to the United Kingdom for R&D purposes. In addition, the Company further bolstered its senior leadership team by adding Shannon Buggy as Senior Vice President, Global Head of People. Management uses adjusted operating loss for planning, forecasting and evaluating business and financial performance, including allocating resources and evaluating results relative to employee compensation targets. ... Was ist denn bei Varta los? McPhy Announces the Success of its Capital Increase € 180m Raised from Strategic Investors, ... Plug Power to Announce 2020 Third Quarter Results, Bombardier-Ingenieurin gewinnt „Clara Jaschke Innovationspreis 2020“. the uncertainties associated with the COVID-19 pandemic, including our ability, and the abilities of our joint ventures and our suppliers and distributors, to effectively deal with the restrictions, limitations and health issues presented by the COVID-19 pandemic, the ability to continue our production, distribution and sale of our products, and demand for and the use of our products by consumers; laws and regulations and any amendments thereto applicable to our business and the impact thereof, including uncertainty regarding the application of United States state and federal law to U.S. hemp (including CBD) products and the scope of any regulations by the U.S. Federal Drug Administration, the U.S. Federal Trade Commission, the U.S. Patent and Trademark Office and any state equivalent regulatory agencies over U.S. hemp (including CBD) products; expectations regarding the regulation of the U.S. hemp industry in the U.S., including the promulgation of regulations for the U.S. hemp industry by the U.S. Department of Agriculture; the grant, renewal and impact of any license or supplemental license to conduct activities with cannabis or any amendments thereof; our international activities and joint venture interests, including required regulatory approvals and licensing, anticipated costs and timing, and expected impact; the ability to successfully create and launch brands and further create, launch and scale U.S. hemp-derived consumer products, including through the acquisition of four Redwood Holding Group, LLC operating subsidiaries (the “Redwood Acquisition”) and cannabis products in jurisdictions where such products are legal and that we currently operate in; the benefits, viability, safety, efficacy, dosing and social acceptance of cannabis including CBD and other cannabinoids; expectations regarding the implementation and effectiveness of key personnel changes; the anticipated benefits and impact of the Altria’s C$2.4 billion (approximately $1.8 billion) investment in us (the “Altria Investment”); the potential exercise of the warrant held by Altria, pre-emptive rights and/or top-up rights in connection with the Altria Investment, including proceeds to us that may result therefrom; expectations regarding the use of proceeds of equity financings, including the proceeds from the Altria Investment; the legalization of the use of cannabis for medical or adult-use in jurisdictions outside of Canada, the related timing and impact thereof and our intentions to participate in such markets, if and when such use is legalized; expectations regarding the potential success of, and the costs and benefits associated with, our joint ventures, strategic alliances and equity investments, including the strategic partnership with Ginkgo Bioworks, Inc.; our ability to execute on our strategy and the anticipated benefits of such strategy; expectations of the amount or frequency of impairment losses, including as a result of the write-down of intangible assets, including goodwill; the ongoing impact of the legalization of additional cannabis product types and forms for adult-use in Canada, including federal, provincial, territorial and municipal regulations pertaining thereto, the related timing and impact thereof and our intentions to participate in such markets; the future performance of our business and operations; our competitive advantages and business strategies; the competitive conditions of the industry; the expected growth in the number of customers using our products; our ability or plans to identify, develop, commercialize or expand our technology and R&D initiatives in cannabinoids, or the success thereof; expectations regarding acquisitions and dispositions and the anticipated benefits therefrom, including the Redwood Acquisition and the acquisition of certain assets from Apotex Fermentation Inc., including a GMP-compliant fermentation and manufacturing facility in Winnipeg, Manitoba, and the proposed sale of our Original B.C.